Merck & Co, Indian Firms On Tackling Supply Chain Risks And A Hijack

Visibility And Digitization Are Key

Merck & Co. executive outlines how the company could sustain a “compliant supply performance” amid the pandemic, while senior officials from Sun Pharma, Cipla, Zydus Cadila and Biocon shared insights on coping with supply chain turbulence and moving away from over-dependence on China for starting materials.

Shipping & Map image

More from COVID-19

More from In Vivo